Myeloid Nuclear Differentiation Antigen (MNDA) Protein Expression in Myelodysplastic Syndrome (MDS) Is Reduced in Maturing Myeloid Cells.
Keith Shults(Center for Innovation), Robert C. Briggs(Vanderbilt University), James W. Jacobberger(University Hospitals Cleveland Medical Center), Stacey Goodman(Texas Oncology), Sara A. McClintock-Treep(Vanderbilt University), Fouad Boulos(Vanderbilt University), Madan Jagasia(Vanderbilt University Medical Center), David R. Head(University of Southern California), Leanne A. Flye(Center for Innovation), Greg Stelzer(Center for Innovation)
Cited by 0
Related Papers
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
|Biology of Blood and Marrow Transplantation|2014|5.4k
Age and acute myeloid leukemia
|Blood|2006|1.4k
Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.
|Journal of Clinical Oncology|1997|1.3k